Physician Profiles

Over 3000 robotic cases done which is the highest number on the West Coast.  

Featured on NBC, click here to read more.

University of Southern California, School of Biomedical Engineering, B.S., 1989 
University of Southern California, School of Medicine, M.D., 1993 

LICENSURE AND CERTIFICATION:

American Board of Obstetrics and Gynecology (OBGYN), Diplomate, 2002 
American Board of Obstetrics and Gynecology (Gyn Onc), Diplomate, 2003 
Florida Board of Medicine, License No. ME-0072654, 1997 
Medical Board of California, License No. G86713, 2002 
National Board of Medical Examiners, Diplomat, 1994

ACADEMIC APPOINTMENTS: 

POSTDOCTORAL TRAINING: 

Torrance Memorial Hospital, Torrance, California 
Little Company of Mary Hospital, Torrance, California 
Prespetarain Intercommunity Hospital, Whittier, California 

BOOKS AND MONOGRAPHS PUBLISHED: 

1. Hervy E. Averette, Ramin Mirhashemi, Roberto Angioli, Manuel A. Peñalver, Ricardo Estape, Radical Hysterectomy in Mastery of  Surgery, 4th Edition, Nyhus,  Baker and Fischer, Editors, 2001.

REFEREED JOURNAL ARTICLES: 

1. Ramin Mirhashemi, Bernard L. Harlow, Elizabeth S. Ginsberg, Lisa Signorello, Ross Berkowitz, Sarah Feldman, Predicting Risk of Complications With Gynecologic Laparoscopic Surgery. Obstet Gynecol 92, 327-331, 1998.
2. Ramin Mirhashemi, Alexander Kratz, Michele M. Weir, Kelly L. Molpus, Annekathryn K. Goodman, Vaginal Small Cell Carcinoma Mimicking a Bartholin’s Gland Abscess: A Case Report. Gynecologic Oncology 68, 297-300, 1998.
3. Manuel A. Penalver, Roberto Angioli, Ramin Mirhashemi, Rizwan Malik. Management of Early And Late Complications of Ileocolonic Continent Urinary Reservoir (Miami Pouch). Gynecologic Oncology 69, 185-191, 1998.
4. Roberto Angioli, Ricardo Estape, Guilherme Cantuaria, Ramin Mirhashemi, Heather Williams, Jorge Martin, Manuel A. Penalver, Urinary Complications of Miami Pouch: Trends of Conservative Management. Am J Obstet Gynecol 179, 343-348, 1998.
5. Ramin Mirhashemi, Wolfgang MJ Schoell, Ricardo Estape, Roberto Angioli, Hervy E. Averette, Trends in the Management of Pelvic Abscesses. J Am College of Surgeons 188:567-572,1999.
6. Ramin Mirhashemi, Mike F. Janicek, Wolfgang MJ Schoell. Critical Care Issues in Cervical Cancer Management. Seminars in Surgical Oncology 16:267-274, 1999.
7. Wolfgang Schoell, Mike F. Janicek, Ramin Mirhashemi. Epidemiology and Biology of Cervical Cancer, Seminars in Surgical Oncology 16:203-211, 1999.
8. Hervy E. Averette, Ramin Mirhashemi, Frederick Moffit. Pregnancy After Breast Cancer: The Ultimate Medical Challenge. Cancer 85:2301-2305, 1999.
9. Wolfgang Schoell, M klintschar, Ramin Mirhashemi, D Strunk, Giuliani A, Bogensberger G, Pertl B. Separation of  Sperm and Vaginal Cells based on Ploidy, MHC Class I, CD45, and Cytokeratin Expression for Enhancement of DNA Typing After Sexual Assault. Cytometry 36:319-323, 1999.
10. Wolfgang Schoell, Ramin Mirhashemi, Eckhard Podack, Manuel Penalver, Bai Liu. Generation of Tumor-Specific Cytotoxic T Lymphocytes by Stimulation with HPV Type 16 E7 Peptide-Pulsed Dendritic Cells: An Approach To Immunotherapy of Cervical Cancer. Gynecol Oncol 74:448-455, 1999.
11. Wolfgang Schoell, M Klintschar, Ramin Mirhashemi, B. Pertl. Separation of Sperm and Vaginal Cells with Flow Cytometry for DNA Typing after Sexual Assault. Obstet and Gynecol 94:623-627, 1999.
12. Roberto Angioli, Ricardo Estape, Emory Salom, Guilherme Cantuaria, Ramin Mirhashemi, Luis Mendez, Richard Yoo, Manuel Penalver. Radical Hysterectomy for Cervical Cancer: Hysterectomy Before Pelvic Lymphadenectomy or Vice Versa? Int J Gynecol Cancer 9:307-311, 1999.
13. Ramin Mirhashemi, Hervy E. Averette, Krishnaprasad Deepika, Michael Rodriguez, Ricardo Estape, Roberto Angioli, Jorge Martin, Manuel Penalver, The Impact of Utilization of The Cell Saver During Type III Radical Hysterectomy for Early Stage Cervical Cancer. Am J Obstet Gynecol 181:1310-1316, 1999.
14. Luis Mendez, Guilherme Cantuaria, Roberto Angioli, Ramin Mirhashemi, C Gabriel, Ricardo Estape, Manuel Penalver. Evaluation of the Pfannenstiel Incision for radical abdominal hysterectomy with pelvic and para-aortic lymphadenectomy. Int J Gynecol Cancer 9:418-420, 1999.
15. Emory Salom, Ramin Mirhashemi, Manuel Penalver. Papillary Squamous Cell Carcinoma of the Uterine Cervix: An Immunophenotypic Appraisal of 12 Cases. Obstet Gynecol 95:S51-S52, 2000.
16. Cantuaria G, Magalhaes A, Angioli R, Mendez L, Mirhashemi R, Wang J, Wang P, Penalver M, Averette H, Braunschweiger P. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma. Cancer 88:381-388, 2000.
17. Mirhashemi R, Averette HE, Estape R, Angioli R, Mahran R, Mendez L, Cantuaria G, Penalver M. Low colorectal anastomosis after radical pelvic surgery: A risk factor analysis. Am J Obstet and Gynecol 183:1375-1380,2000.
18. Mirhashemi R, Angioli R, Cantuaria G, Penalver R, Extraperitoneal Approach to the Aortic Nodes. CME J Gynecologic Oncology 15:122-127, 2000.
19. Ramin Mirhashemi, Wilberto Nieves-Neira. Hereditary Gynecologic Malignancies; Current Trends in Management. The Female Patient 26:38-50, 2001.
20. Mirhashemi R, Nieves-Neira W, Averette HE, Gynecologic malignancies in older women. Oncology 15:580-586, 2001.
21. Ramin Mirhashemi, Nicholas Lambrou, Robert L. Coleman, Vaginal reconstruction in  gynecologic oncology. Women’s Oncol Rev 2:13-18,2002.    
22. Frederck L. Moffat, Joyce Lentz, Ramin Mirhashemi, Hervy E. Averette, Referral strategies for new breast abnormalities. Contemporary OB/GYN:4-7,2002.
23. Lambrou NC, Mirhashemi R, Wolfson A, Thesiger P, Penalver M. Malignant peripheral nerve sheath tumor of the vulva: a multimodal treatment approach. Gynecol Oncol. 2002 May;85(2):365-71.
24. Mirhashemi R, Cancer and Pregnancy. NEJM 2002 June;346:1921
25. Salom E, Almeida Z, Mirhashemi R. Management of recurrent ovarian cancer: Evidence-based decisions. Curr opin oncol  14(5):519-527;2002.
26. Mirhashemi R, Averette HE, Lambrou N, Penalver MA, Mendez l, Ghurani, G, Salom E. Vaginal reconstruction at the time of pelvic exenteration: A surgical and psychosexual analysis of techniques. Gynecol Oncol 2002;87:39-45.
27. Mirhashemi R, Lambrou. Vaginal reconstruction and the gynecologic oncologist. Female Patient. Septmeber 2002;27:1-6.
28. Roberto Angioli, Pierluigi Bendetti Panici, Ramin Mirhashemi, Luis Mendez, Guillherme Canturia, Stefano Basile, Manuel Penalver. Continent urinary diversion and low colorectal anastomosis after pelvic exenteration. Quality of life and complication risk. Crit Rev Oncol Hematol 2003 Dec;48(3):281-5.
29. Roberto Angioli, Manuel Penalver, Ludovico Muzii, Luis Mendez, Ramin Mirhashemi, Filippo Bellati, Clara Croce, Pierluigi Benedetti Panici. Guidelines of how to manage vesicovaginal fistula. Crit Rev Oncol Hematol 2003 Dec;48(3):295-304.
30. Ramin Mirhashemi, Parvin Ganjei, Mehrdad Nadji, Nicholas Lambrou, Fikret Atamdede, Hervy Averette. Papillary squamous cell carcinoma of the uterine cervix: an immunophenotypic appraisal of 12 cases. Gynecol Oncol 2003;90:657-661.
31. Ramin Mirhashemi, Nicholas Lambrou. Reply to the Editor; Gynecol Oncol 2003;90:691.
32. Ramin Mirhashemi, Arena JF, Frudakis T, Lambrou N, Arboleda J, Averette H, Penalver MA. Candidate gene in predicting in vivo ovarian cancer response to combination therapy with paraplatin and Paclitaxel. ScientificWorldJournal. 2002 Jan 2;2(1 Suppl 2):19-20.
33. Ramin Mirhashemi, Averette H,  Lambrou N, Penalver MA, Hus N, Salom E.  The gastrointestinal complications of the Miami Pouch: A review of  77 cases. Gynecol Oncol 2004;92:5-10.
34. Lambrou N, Gomez-Marin O, Ramin Mirhashemi,  Beach H, Salom E,  Almeida-Parra Z, Penalver M. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival.  Gynecol Oncol. 2004 Jun;93(3):653-8.
35. Ramin Mirhashemi, Samuel Im, Tajnoos Yazdani. Urinary diversion following radical pelvic surgery. Curr Opin Obstet Gynecol. 2004 Oct;16(5):419-22.
36. O’Connell C, Ramin Mirhashemi, Kassira N, Lambrou N, McDonal WS. Formation of Functional Neovagina With Vertical Rectus Abdominis Musculocutaneous (VRAM) Flap After Total Pelvic Exenteration. Ann Plast Surg. 2005 Nov;55(5):470-473.

OTHER WORKS, PUBLICATIONS AND ABSTRACTS: 

1. Ramin Mirhashemi, Liu B.C.C., DeKernion J.B., Fahey J.L., Oncogenes and Bladder Tumor Progression, Organ Systems Newsletter, 1987.
2. Ramin Mirhashemi, Detection of Protein Products from Transfected Metastatic Variant Cell Lines, UCLA Research Symposium, 1987.
3. Ramin Mirhashemi, Bai Liu, Anne O’Meara, Manuel Penalver, Roberto Angioli,  Mike Janicek., Poor Immunogenic Phenotypes of a Cervical Small Cell Carcinoma Cell Line, Poster Presentation, 70th Scientific Session of the World Cancer Congress, August 1998.
4. Rizwan Malik, Ramin Mirhashemi, Manuel Penalver. Adrenal Rest Tumor of the Ovary: A Case Presentation and Review of the Literature, Oral Presentation at the Annual Southern Medical Association, New Orleans, Louisiana, October, 1998.
5. Angioli R, Janicek MF, Estape RE, Cantuaria G, Mirhashemi R, Averette HE, Penalver M. Evaluation of the Inteaction of Topotecan and Cisplatin in Human Ovarian Fresh Tumor Tissue and Established Cell Lines. Abstract Meeting of the Soceity of Gynecologic Oncology 1998.
6. Ramin Mirhashemi, Bai Liu, Wolfgang Schoell, Manuel Penalver, Roberto Angioli, Mike Janicek, Generation of Cytotoxic T-Lymphocytes Specific for Cervical Carcinoma, Poster Presentation, 70th Scientific Session of the World Cancer Congress, August 1998
7. Roberto Angioli., Guiherme Cantuaria., Hervey Averette, Ricardo Estape., Ramin Mirhashemi, Manule Penalver, Treatment of Ovarian Cancer with the Combination of Topotecan and Cisplatin: An In Vitro Study, Poster Presentation, 70th Scientific Session of the World Cancer Congress, August 1998
8. Ramin Mirhashemi, Manuel Penalver, Parvin Ganjei-Azar. Retroperitoneal Anaplastic Lymphoma Secondary to Combination Chemotherapy for Immature Teratoma of the Ovary. Oral Presentation at the 29th Annual George Papanicolaou Seminar in Gynecologic Pathology, Southern Medical Association 1999.
9. Ramin Mirhashemi, Rizwan Malik, Parvin Ganjei. Metastatic Melanoma of the Ovary. Oral Presentation at the 29th Annual George Papanicolaou Seminar in Gynecologic Pathology, Southern Medical Association 1999.
10. Ling Du, Ramin Mirhashemi, Manuel Penalver, Eckhard Podack, Bail Liu. Expression of HSP-70Binding Elements on Peripheral Blood Mononuclear Cells.  Poster, Sylvester Cancer Center Poster Session, June 1999.
11. Bai Liu, Ling Du, B. Adkins, Y. Bu, R.L. Miller, Ramin Mirhashemi, Manuel Penalver, Mike Janicek, Eckhard Podack. An Imiquimod Analogue, R848, Induces Murine Macrophages to Produce Nitric Oxide. Poster, Sylvester Cancer Center, June 1999.
12. Ramin Mirhashemi, Mehrdad Nadji, Emory Salom, Ricardo Estape, Wolfgang MJ Schoell, Manuel Penalver, Parvin Ganjei-Azar. Papillary Squamous Carcinoma of the Uterine Cervix: An Immunophenotypic Appraisal of 12 cases. Abstract, SGO, March 1999.
13. Ramin Mirhashemi, Wolfgang MJ Schoell, Mike F. Janicek, Manuel Penalver, Ricardo Estape, Roberto Angioli, Bail Liu. Significant Downregulation of HLA Class I Molecules and Absence of Co-Stimulatory Molecules (ICAM-1, CD40, and CD82) in Small Cell Carcinoma of the Uterine Cervix: A Mechanism for in vivo Escape from Immunosurveillance. Abstract, SGO, March 1999.
14. Ramin Mirhashemi, Scott Kammel, Parvin Ganjei-Azar, Rizwan Malik, Mehrdad Nadji, Manuel Penalver.Villoglandular Adenocarcinoma of the Uterine Cervix: A Clinical and Immunophenotypic Assessment of 12 Cases. Abstract, SGO, March 1999.
15. Wolfgang Schoell, Ramin Mirhashemi, Mike F. Janicek, Manuel Penalver, Ricardo Estape, Eckhard Podack, Bail Liu. In Vitro Production of Tumor-Specific Cytotoxic T-Lymphocytes (CTLs) by Stimulation with Synthetic Human Papillomavirus Type 16 E7 Peptide for Immunotherapy of Cervical Cancer. Abstract, SGO, March 1999.
16. Guilherme Cantuaria, Roberto Angioli, Ramin Mirhashemi, Luiz Mendez, Ricardo Estape, Manuel Penalver. Primary Malignant Melanoma of the Uterine Cervix: Case Report and Review of the Literature. Abstract, SGO, March 1999.
17. Ricardo Estape, Nailim Milian, Roberto Angioli, Guilherme Cantuaria, Ramin Mirhashemi, Luiz Mendez, Manuel Penalver. Incompletely Staged Germ Cell Tumors: Is Staging Necessary? Abstract, SGO, March 1999.
18. Ricardo Estape, Roberto Angioli, Luiz Mendez, Guilherme Cantuaria, Ramin Mirhashemi, Marsha Hunt, Manuel Penalver. 3-Day BEP for Ovarian Germ Cell Tumors, Abstract, SGO, March 1999.
19. Ricardo Estape, Douglas Moffet, Roberto Angioli, Guilherme Cantuaria, Ramin Mirhashemi, Luis Mendez, Manuel Penalver. Hysterectomy versus Conservative Management of Recurrent Cervical Dysplasia: A Cost-Benefit Analysis. Abstract, SGO, March 1999.
20. Wolfgang MJ Schoell, Ramin Mirhashemi, Bai Liu, Raimund Winter. Imiquimod Zur Therapie Genitaler Condylome: Klinische Ergebnisse, Wirkungsmechanismus und Zukunftsperspektiven. Presented at the Annual Gynecologic Oncology Conference, Munich, Germany, June 1999.
21. 'Wolfgang MJ Schoell, Ramin Mirhashemi, Bai Liu, Raimund Winter. Immunotherapie des HPV-Assoziierten Zervixkarzinomes Durch in vitro Produktion Tumorspecifischer Zytotoxischer T Lymphozyten. Presented at the Annual Gynecologic Oncology Conference, Munich, Germany, June 1999.
22. Ramin Mirhashemi, Bernard L. Harlow, Elizabeth S. Ginsberg, Lisa B. Signorello, Ross Berkowitz, Sarah Feldman, Risk of Complications Following Gynecologic Laparoscopic Surgery, Poster Presentation, ACOG 46th Annual Clinical Meeting
23. Ramin Mirhashemi, Hervy E. Averette, Manuel A. Peñalver. Vaginal reconstruction Following pelvic exenteration: A review of 21 cases. Poster Presentation, 32nd Annual Meeting, Society of Gynecologic Oncologists, 2001.
24. Ramin Mirhashemi, J.Fernando Arena, Tony Frudakis, Nicholas Lambrou, Jane Arboleda, Marsha Hunt, Maria Medranda, Hervy Averette, and Manuel Penalver.  Candidate Gene in Predicting in-vivo Ovarian Cancer Response to Combination Therapy with Paraplatin and Paclitaxel.  Poster Presentation at the Miami Nature Biotechnology Winter Symposium, Miami, Florida, 2002.
25. Ramin Mirhashemi, J.Fernando Arena, Nicholas Lambrou, Jane Arboleda, Marsha Hunt, Maria Medranda, Hervy Averette, Manuel Penalver, Matthew Thomas, Zack Gaskin, Siva Gunjupulli, Venkateswarlu Kondragunta, Ponnuswamy Kolathupalayam  Nachimuthu, Ponnuswamy Visu, Sivamiani Natarajan, Sitarama Gunturi, Tony Frudakis. Determination of a Candidate Gene in Predicting in-vivoOvarian Cancer Response to Combination Therapy with Paclitaxel and Carboplatin.  Oral Presentation at the 33rd Annual Meeting of the Society of Gynecologic Oncologists, Miami Beach, Florida, 2002.
26. Mirhashemi R, Salom E, Lambrou N, Almeida Z, Auguste FA. Topotecan and doxorubicin HCL liposome combination therapy in the treatment of recurrent/refractory ovarian cancer: A phase II study . Abstract, ASCO 2003
27. Hurly J, Mirhashemi R. Breast cancer in the Bahamas: Preliminary evidence for a high incidence of genetic risk. Abstract, ASCO 2003.
28. Mirhashemi R, Arena JF, Frudakis T.  Determination of a candidate gene in predicting in-vivo ovarian cancer response to combination therapy with paclitaxel and carboplatin. ASCO,  Abstract, ASCO 2003. 

BOOK CHAPTERS:

1. Averette HE, Mirhashemi R, Angioli R, Estape R, Penalver MA. Radical Hysterectomy. In Baker RJ and Fisher JE (eds). Mastery of Surgery. 4th edition. Lippincott, Williams, and Wilkins Publishers. 2002.

FUNDED RESEARCH:

Department of OB-GYN, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA. 
Genetic Susceptibility to cervical cancer in second hand smoke 
Principle Investigator: Ramin Mirhashemi, M.D. _ 25% 
Funding: Flight Attendants Medical Research Institute 
7/01/03 – 7/01/05    $210,000 Total Award ($200,000 direct/$10,000 indirect)

Department of OB-GYN, University of Miami, School of Medicine 
PHASE II STUDY OF TOPOTECAN (HYCAMTIN) AND DOXORUBICIN HCL LIPOSOME (DOXIL) IN RECURRENT/REFRACTORY OVARIAN CANCER. 
Principal Investigator: Ramin Mirhashemi, M.D. – 25% 
Funding: SmithKline Beecham Oncology 
04/01/01 – 10/31/02    $140,000 Total Award ($109,600 direct/$27,400 indirect)

Department of OB-GYN, University of Miami, School of Medicine 
PHASE II STUDY OF TOPOTECAN (HYCAMTIN) AND DOXORUBICIN HCL LIPOSOME (DOXIL) IN RECURRENT/REFRACTORY OVARIAN CANCER. 
Principal Investigator: Ramin Mirhashemi, M.D. – 25% 
Funding: Alza Corporation 
04/01/01 – 9/30/02    $80,000 Total Award ($61,600 direct/$15,400 indirect) 

Department of OB-GYN, University of Miami, School of Medicine 
PHASE II STUDY OF NESP (Novel Erythrpoeisis Stimulating Protein) DURING CONCURRENT CHEMO-RADIATION FOR THE TREATMENT OF CERVICAL CARCINOMA. 
Principal Investigator: Ramin Mirhashemi, M.D. – 5% 
Funding: AMGEN, Inc. 
05/01/01 – 03/30/03    $165,000 Total Award ($132,675 direct/$32,325 indirect)

Department of OB-GYN, University of Miami, School of Medicine 
Pharmacogenomics Approach to the Treatment of Ovarian Cancer 
Principal Investigator: Ramin Mirhashemi, M.D. – 0% 
Funding: DNAPrint Genomics Inc. 
01/01/02 – 12/31/02    $120,000 Total Award ($95,000 direct/$25,000 indirect)

Department of Microbiology/Immunology, Sylvester Comprehensive Cancer 
Center University of Miami, School of Medicine 
Heat Shock Protein Vaccine for the Treatment of Cervical Cancer 
Principal Investigator: Ramin Mirhashemi 
Funding: ACOG + The Miami-Aids NIH Training Grant) 
1998 - 2000 
Gynecologic Oncology Research Laboratory, Sylvester Comprehensive Cancer 
Center University of Miami, School of Medicine 
Generation of E6/E7 Peptide Specific CTLs for Adoptive Immunotherapy of 
Cervical Cancer 
Principal Investigators: Ramin Mirhashemi, M.D. 
Funding: Sylvester Comprehensive Cancer Center Grant + 3M  Pharmaceuticals 
1997 - 1998

Department of Gynecologic Oncology, Brigham and Women’s Hospital, Harvard 
Medical School 
Prognostic Variables for Complications in Operative Laparoscopy 
Principle Investigators: Ramin Mirhashemi, M.D. 
1995-1997

Department of Microbiology/Immunology, Division of Urology 
University of California at Los Angeles, School of Medicine 
Investigation of a Tumor Specific Protein Marker Involved in Early Detection of Metastatic Murine Carcinoma Cells. 
Principle Investigator: J. B. DeKernion, M.D. 
1986 -1988

PROFESSIONAL AND HONORARY ORGANIZATIONS:

• International Gynecologic Cancer Society
• Florida Society of Gynecologic Oncologists
• Alpha Omega Alpha Medical Honor Society
• American College of Obstetricians and Gynecologists
• American College of Surgeons
• American Medical Association
• Society of Gynecologic Oncologists
• Society of Gynecologic Surgeons
• The American Association of Gynecologic Laparoscopists

ADVISORY BOARDS:

COMMITTEES: 

HONORS AND AWARDS:

ORAL PRESENTATIONS:

1. Oral Plenary Presentation at Annual Meeting Of the Society of Pelvic Surgeons, The Management of Bulky IB2 Cervical Cancer: Is there a Role? Novembner 2003
2. Oral plenary presentation at the Annual Society of Gynecologic Oncologists, Development of a Targeted BRCA1/BRCA2 Mutation Screening Panel for African-American Women. February 2003.
3. Oral plenary presentation at the Annual Society of Gynecologic oncologists, A Pharmacogenetic classifier for predicting in-vivo response to combination therapy with paclitaxel and carboplatin. March 2002.
4. Oral Plenary Presentation at the Annual American Society of Human Genetics, Polymorphisms Predict Ovarian Cancer Response, October 2002.
5. Oral Plenary Presentation at Annual Meeting Of the Society of Pelvic Surgeons, The Gastrointestinal Complications of the Miami Pouch, Novembner 2002
6. Grand Rounds presentation: University of Pittsburg, Magee Women’s Hospital, BRCA 1 the Ultimate Tumor Suppresor Gene. October 2002.
7. Grand Rounds Presentation: University of South Florida, Cervical Cancer and HPV: Molecular and Epidemiologic Perspectives, November 2002.
8. Oral Presentation: Society of Pelvic Surgeons, Vaginal Reconstruction after Pelvic  Exenteration: A review of 25 cases. July 2001.
9. Clinical Moderator: 29th Annual George Papanicolaou Memorial Seminar in Gynecologic Pathology. November 1999
10. Grand Rounds Presentation: Harvard Medical  School, Brigham and Women’s Hospital, Fetal Obstructive Uropathy; Current Trends in Management and Treatment. 1994
11. Grand Rounds Presentation: Harvard Medical School, Brigham and Women’s Hospital, Chemotherapy Induced Ovarian Failure; New Horizons, 1995
12. Grand Rounds Presentation: Harvard Medical School, Brigham and Women’s Hospital, Risk of Complications of Gynecologic Laparoscopic Surgery, The Brigham and Women’s Hospital Experience, 1997
13. Ground Rounds Presentation: University of Miami, School of Medicine,  Update in the Genetics of Gynecologic Malignancies, 2000
14. Oral Presentation (Fellow Paper Award): William A. Little Society Annual Meeting,  Immunotherapy of Cervical Cancer. 1998
15. Poster Presentation (First prize, Fellow Abstract Award): Sylvester Comprehensive Cancer Center, Poor Immunogenic Phenotype of a Cervical Small Cell Carcinoma Cell Line, 1998, 1999
16. Oral Presentation: University of Miami Annual Boards Review Course, Endometrial Cancer, 1998
17. Oral Presentation: University of Miami Symposium; Women and Cancer Approaching the Second Millenium, Cervical Cancer: The Present, Past, and the Future, November 1998.
18. Faculty Speaker: Third Annual Diabetes/Osteoporosis Symposium, Cedars Medical Center, Miami Florida, Postmenopausal Treatment of Osteoporosis, January 1999.
19. Grand Rounds Presentation: Department of Anesthesiology, University of Miami School of Medicine, Intraoperative Autologous Transfusion in Gynecologic Surgery, February 1999.
20. Oral Presentation: Annual Meeting of the Society of Gynecologic Surgeons, The Impact of the Utilization of the Cell Saver During Type III Radical Hysterectomy for Early Stage Cervical Cancer, February 21, 1999. San Diego, California
21. Oral Presentation: Annual Meeting of SmithKline Gynecologic Oncology Fellows Forum, Cell Saver in Radical Pelvic Surgery, February 27, 1999, Dana Point California
22. CME Guest Faculty Lecture, Annual IAMA meeting, Screening for Breast Cancer,  May 1999, Miami Beach Florida
23. Best Fellow Presentation “William Little Society”, Generation of HPV 16 E7 Peptide Specific CTLs Using Dendritic Cells as Stimulators, May 1999, Senosta Beach Florida
24. Grand Rounds Presentation “Novel Therapeutic Horizons in the Treatment of Cervical  Dysplasia”, July 2000, Mt. Sinai Department of Obstetrics and Gynecology, Miami, FL.
25. Grand Rounds Persentation. Breast and Ovarian Cancer Syndromes, November 2000, Baptist Health Care System Department of Obstetrics and Gynecology.
26. Guest Speaker. Controversial Issues in the Management of Endometrial Carcinoma,  February 2001, Post Graduate Course in Obstetrics and Gynecology University of Miami Raddison Hotel, Miami Beach, Florida.
27. Guest Lecturer. Familial Ovarian and Breast Cancer Syndromes, April 2001, Ft.  Lauderdale OBGYN Society, Ft. Lauderdale, Florida.

INVITED LECTURES:

1. Visiting Professor, University of Florida Department of OBGYN, October 2003.
2. Visiting Professor , Sylvester Comprehensive Cancer Center, September 2003.
3. Grand Rounds: MD Anderson Cancer Center, June 2003
4. Ovarian Cancer Panel Speaker, SGO ovarian cancer Satellite Sympsium, 2003.
5. Grand Rounds: University of Florida. 2002
6. Grand Rounds: Bethesda Medical Center. 2002
7. Guest Speaker: Florida Society of Gynecologic Oncologists. 2002
8. Grand Rounds: University of Texas, Southwestern Medical School. 2000
9. Moderator and Speaker: Annual Interamerican Breast Cancer Conference. Cancun 2002

NATIONAL STUDIES: 

1. Gynecologic Oncology Group, Co- Principle Investigator:    Ramin Mirhashemi, M.D. 

EXTRACURRICULAR ACTIVITIES AND HOBBIES: